 <h1>Nplate Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>romiplostim</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about romiplostim. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Nplate.</p><h2>In Summary</h2><p><b>Common side effects of Nplate include:</b> abdominal pain, dizziness, insomnia, limb pain, and myalgia. <b>Other side effects include:</b> dyspepsia, paresthesia, and shoulder pain.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to romiplostim: subcutaneous powder for solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, romiplostim (the active ingredient contained in Nplate) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking romiplostim:</p><p>
<i>More common</i>
</p><ul>
<li>Bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>body aches or pain</li>
<li>change in hearing</li>
<li>chills</li>
<li>cough</li>
<li>diarrhea</li>
<li>difficulty breathing</li>
<li>ear congestion or pain</li>
<li>ear drainage</li>
<li>fever</li>
<li>headache</li>
<li>loss of appetite</li>
<li>loss of voice</li>
<li>nausea</li>
<li>pain or tenderness around the eyes and cheekbones</li>
<li>rapid weight gain</li>
<li>sneezing</li>
<li>sore throat</li>
<li>stomach pain</li>
<li>stuffy or runny nose</li>
<li>tightness of the chest</li>
<li>tingling of the hands or feet</li>
<li>unusual tiredness or weakness</li>
<li>unusual weight gain or loss</li>
<li>upper stomach pain</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Burning pain, warmth, swelling, or redness of the hands and feet</li>
<li>fast heartbeat</li>
<li>feeling of warmth</li>
<li>hives, itching, skin rash</li>
<li>hoarseness</li>
<li>irritation</li>
<li>joint pain, stiffness, or swelling</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals</li>
<li>redness of the skin</li>
<li>troubled swallowing</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of romiplostim may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Belching</li>
<li>bruise</li>
<li>difficulty with moving</li>
<li>diarrhea</li>
<li>dizziness</li>
<li>headache</li>
<li>heartburn</li>
<li>indigestion</li>
<li>mouth or throat pain</li>
<li>muscle pains, cramps, or stiffness</li>
<li>pain in the shoulder, arms, or legs</li>
<li>stomach discomfort, upset, or pain</li>
<li>trouble sleeping</li>
</ul><p>
<!-- end subcutaneous powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to romiplostim: subcutaneous powder for injection</i></p><h3>General</h3><p>The most serious adverse reactions were increased bone marrow reticulin, thrombotic/thromboembolic complications, and progression of myelodysplastic syndromes (MDS) to acute myelogenous leukemia (AML).<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Serious bleeding events included any event that was fatal, life-threatening, required hospitalization or prolongation of hospitalization, caused persistent or significant disability/incapacity, congenital anomaly/birth defect, and any other significant hazard.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Grade 2 or higher bleeding event (15%)</p>
<p><b>Common</b> (1% to 10%): Bone marrow reticulin formation increased 2 grades or more, bone marrow collagen fibrosis increased to grade 4, grade 4 bone marrow collagen fibrosis, bone marrow disorder, thrombocytopenia, anemia, thrombocytosis, bone marrow reticulin deposition, anemia, reticulin increased, serious bleeding event</p>
<p><b>Uncommon</b> (0.1% to 1%): Aplastic anemia, bone marrow failure, leukocytosis, splenomegaly, thrombocythemia, platelet count increased, platelet count abnormal, blood lactate dehydrogenase increased</p>
<p><b>Frequency not reported</b>: Marrow fibrosis with collagen<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Palpitations, flushing, hematoma, hypertension, peripheral ischemia, peripheral embolism</p>
<p><b>Uncommon</b> (0.1% to 1%): Myocardial infarction, heart rate increased, deep vein thrombosis, hypotension, phlebitis, thrombophlebitis superficial, thrombosis, erythromelalgia, blood pressure increased</p>
<p><b>Frequency not reported</b>: Congestive heart failure<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): B-cell lymphoma</p>
<p><b>Uncommon</b> (0.1% to 1%): Multiple myeloma, myelofibrosis</p>
<p><b>Frequency not reported</b>: Progression of myelodysplastic syndromes (MDS) to acute myelogenous leukemia (AML), blast cell counts transiently increased<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 36.2%), dizziness (up to 17%)</p>
<p><b>Common</b> (1% to 10%): Paresthesia, migraine</p>
<p><b>Uncommon</b> (0.1% to 1%): Clonus, dysgeusia, hypoesthesia, hypogeusia, neuropathy peripheral, transverse sinus thrombosis, vertigo<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (up to 31%), nasopharyngitis (up to 26.2%), oropharyngeal pain (up to 25%), epistaxis (22.6%), cough (up to 17.3%)</p>
<p><b>Common</b> (1% to 10%): Pulmonary embolism, sinusitis, bronchitis, dyspnea, nasal congestion, rhinorrhea</p>
<p><b>Uncommon</b> (0.1% to 1%): Dry throat, painful respiration</p>
<p><b>Frequency not reported</b>: Upper respiratory tract infection, pneumonia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Arthralgia (up to 26%), back pain (up to 15.8%), pain in extremity (up to 15.6%), myalgia (up to 14%)</p>
<p><b>Common</b> (1% to 10%): Shoulder pain, muscle spasms, bone pain, musculoskeletal pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Muscle tightness, muscle weakness, muscle twitching<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Contusion (up to 41%), pyrexia (up to 24%), fatigue (up to 23.3%)</p>
<p><b>Common</b> (1% to 10%): Influenza-like illness, pain, asthenia, chills, injection site reaction, chest pain, peripheral swelling</p>
<p><b>Uncommon</b> (0.1% to 1%): Injection site hemorrhage, malaise, feeling hot, feeling jittery, body temperature increased<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (up to 20%), nausea (up to 19.4%), upper abdominal pain (14%), abdominal pain (up to 11%), vomiting (up to 10.5%)</p>
<p><b>Common</b> (1% to 10%): Dyspepsia, gastroenteritis, constipation, gingival bleeding, mouth hemorrhage, upper abdominal pain, toothache</p>
<p><b>Uncommon</b> (0.1% to 1%): Rectal hemorrhage, breath odor, dysphagia, gastroesophageal reflux disease, hematochezia, stomach discomfort, stomatitis, tooth discoloration<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Petechiae (18.6%), rash (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Angioedema, pruritus, ecchymosis, purpura, urticaria</p>
<p><b>Uncommon</b> (0.1% to 1%): Alopecia, photosensitivity reaction, acne, dermatitis contact, dry skin, eczema, erythema, exfoliative rash, hair growth abnormal, prurigo, rash papular, rash pruritic, skin nodule, skin odor abnormal, face edema<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (up to 16%)</p>
<p><b>Common</b> (1% to 10%): Anxiety</p>
<p><b>Uncommon</b> (0.1% to 1%): Depression, abnormal dreams, irritability<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Peripheral edema (up to 12.5%)</p>
<p><b>Common</b> (1% to 10%): Hypokalemia</p>
<p><b>Uncommon</b> (0.1% to 1%): Alcohol intolerance, anorexia, appetite decreased, dehydration, gout, weight decreased, weight increased<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Antibodies to this drug (up to 16%)</p>
<p><b>Common</b> (1% to 10%): Preexisting antibodies to this drug, influenza, ear infection</p>
<p><b>Uncommon</b> (0.1% to 1%): Localized infection, neutralizing antibodies</p>
<p><b>Frequency not reported</b>: Hypersensitivity<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p>
<p><b>Uncommon</b> (0.1% to 1%): Protein urine present, vaginal hemorrhage<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Conjunctival hemorrhage, accommodation disorder, blindness, eye disorder, eye pruritus, lacrimation increased, papilledema, visual disturbances<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Portal vein thrombosis, transaminase increased<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Nplate (romiplostim)." Amgen USA, Thousand Oaks, CA. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Nplate (romiplostim)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>3 Reviews</li>
<li>Drug class: platelet-stimulating agents</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nplate &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Idiopathic Thrombocytopenic Purpura</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to romiplostim: subcutaneous powder for injection</i></p><h3>General</h3><p>The most serious adverse reactions were increased bone marrow reticulin, thrombotic/thromboembolic complications, and progression of myelodysplastic syndromes (MDS) to acute myelogenous leukemia (AML).<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Serious bleeding events included any event that was fatal, life-threatening, required hospitalization or prolongation of hospitalization, caused persistent or significant disability/incapacity, congenital anomaly/birth defect, and any other significant hazard.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Grade 2 or higher bleeding event (15%)</p><p><b>Common</b> (1% to 10%): Bone marrow reticulin formation increased 2 grades or more, bone marrow collagen fibrosis increased to grade 4, grade 4 bone marrow collagen fibrosis, bone marrow disorder, thrombocytopenia, anemia, thrombocytosis, bone marrow reticulin deposition, anemia, reticulin increased, serious bleeding event</p><p><b>Uncommon</b> (0.1% to 1%): Aplastic anemia, bone marrow failure, leukocytosis, splenomegaly, thrombocythemia, platelet count increased, platelet count abnormal, blood lactate dehydrogenase increased</p><p><b>Frequency not reported</b>: Marrow fibrosis with collagen<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Palpitations, flushing, hematoma, hypertension, peripheral ischemia, peripheral embolism</p><p><b>Uncommon</b> (0.1% to 1%): Myocardial infarction, heart rate increased, deep vein thrombosis, hypotension, phlebitis, thrombophlebitis superficial, thrombosis, erythromelalgia, blood pressure increased</p><p><b>Frequency not reported</b>: Congestive heart failure<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): B-cell lymphoma</p><p><b>Uncommon</b> (0.1% to 1%): Multiple myeloma, myelofibrosis</p><p><b>Frequency not reported</b>: Progression of myelodysplastic syndromes (MDS) to acute myelogenous leukemia (AML), blast cell counts transiently increased<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 36.2%), dizziness (up to 17%)</p><p><b>Common</b> (1% to 10%): Paresthesia, migraine</p><p><b>Uncommon</b> (0.1% to 1%): Clonus, dysgeusia, hypoesthesia, hypogeusia, neuropathy peripheral, transverse sinus thrombosis, vertigo<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (up to 31%), nasopharyngitis (up to 26.2%), oropharyngeal pain (up to 25%), epistaxis (22.6%), cough (up to 17.3%)</p><p><b>Common</b> (1% to 10%): Pulmonary embolism, sinusitis, bronchitis, dyspnea, nasal congestion, rhinorrhea</p><p><b>Uncommon</b> (0.1% to 1%): Dry throat, painful respiration</p><p><b>Frequency not reported</b>: Upper respiratory tract infection, pneumonia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Arthralgia (up to 26%), back pain (up to 15.8%), pain in extremity (up to 15.6%), myalgia (up to 14%)</p><p><b>Common</b> (1% to 10%): Shoulder pain, muscle spasms, bone pain, musculoskeletal pain</p><p><b>Uncommon</b> (0.1% to 1%): Muscle tightness, muscle weakness, muscle twitching<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Contusion (up to 41%), pyrexia (up to 24%), fatigue (up to 23.3%)</p><p><b>Common</b> (1% to 10%): Influenza-like illness, pain, asthenia, chills, injection site reaction, chest pain, peripheral swelling</p><p><b>Uncommon</b> (0.1% to 1%): Injection site hemorrhage, malaise, feeling hot, feeling jittery, body temperature increased<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (up to 20%), nausea (up to 19.4%), upper abdominal pain (14%), abdominal pain (up to 11%), vomiting (up to 10.5%)</p><p><b>Common</b> (1% to 10%): Dyspepsia, gastroenteritis, constipation, gingival bleeding, mouth hemorrhage, upper abdominal pain, toothache</p><p><b>Uncommon</b> (0.1% to 1%): Rectal hemorrhage, breath odor, dysphagia, gastroesophageal reflux disease, hematochezia, stomach discomfort, stomatitis, tooth discoloration<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Petechiae (18.6%), rash (up to 15%)</p><p><b>Common</b> (1% to 10%): Angioedema, pruritus, ecchymosis, purpura, urticaria</p><p><b>Uncommon</b> (0.1% to 1%): Alopecia, photosensitivity reaction, acne, dermatitis contact, dry skin, eczema, erythema, exfoliative rash, hair growth abnormal, prurigo, rash papular, rash pruritic, skin nodule, skin odor abnormal, face edema<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (up to 16%)</p><p><b>Common</b> (1% to 10%): Anxiety</p><p><b>Uncommon</b> (0.1% to 1%): Depression, abnormal dreams, irritability<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Peripheral edema (up to 12.5%)</p><p><b>Common</b> (1% to 10%): Hypokalemia</p><p><b>Uncommon</b> (0.1% to 1%): Alcohol intolerance, anorexia, appetite decreased, dehydration, gout, weight decreased, weight increased<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Antibodies to this drug (up to 16%)</p><p><b>Common</b> (1% to 10%): Preexisting antibodies to this drug, influenza, ear infection</p><p><b>Uncommon</b> (0.1% to 1%): Localized infection, neutralizing antibodies</p><p><b>Frequency not reported</b>: Hypersensitivity<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p><p><b>Uncommon</b> (0.1% to 1%): Protein urine present, vaginal hemorrhage<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Conjunctival hemorrhage, accommodation disorder, blindness, eye disorder, eye pruritus, lacrimation increased, papilledema, visual disturbances<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Portal vein thrombosis, transaminase increased<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Nplate (romiplostim)." Amgen USA, Thousand Oaks, CA. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about Nplate (romiplostim)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>3 Reviews</li>
<li>Drug class: platelet-stimulating agents</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nplate &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Idiopathic Thrombocytopenic Purpura</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>